{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:40:08Z","timestamp":1784806808851,"version":"3.55.0"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:00:00Z","timestamp":1750982400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Italian Medicines Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.phrs.2025.107843","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:12:33Z","timestamp":1751425953000},"page":"107843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Trend in the use of biological drugs in pediatric patients with immune-mediated inflammatory diseases: Insight from the large-scale Italian VALORE project"],"prefix":"10.1016","volume":"218","author":[{"given":"Chiara","family":"Bellitto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylenia","family":"Ingrasciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Soardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Spini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"L\u2019Abbate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Carollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tuccori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Leoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenica","family":"Ancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Stella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Cavazzana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Scapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Belleudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ledda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Carta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian","family":"Ejlli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Sapigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Puccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Francesca","family":"Scarpelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovambattista","family":"De Sarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Gini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Allotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano Addario","family":"Pollina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaolo","family":"Bucaneve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antea Maria Pia","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Balducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilenia","family":"Senesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Trama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Futura","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Da Cas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana Anna Maria","family":"Urru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Campomori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Spila Alegiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Massari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romina","family":"Gallizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1147-7296","authenticated-orcid":false,"given":"Gianluca","family":"Trifir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2025.107843_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/pgmj.2006.052688","article-title":"Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution","volume":"83","author":"Kuek","year":"2007","journal-title":"Postgrad. Med. J."},{"key":"10.1016\/j.phrs.2025.107843_bib2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.38615","article-title":"Review: Is There a Window of Opportunity for Treatment of Systemic Juvenile Idiopathic Arthritis?","volume":"66","author":"Nigrovic","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.phrs.2025.107843_bib3","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(11)60244-4","article-title":"Juvenile idiopathic arthritis","volume":"377","author":"Prakken","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2025.107843_bib4","article-title":"Patterns and determinants of response to novel therapies in juvenile and adult-onset polyarthritis","author":"Triaille","year":"2023","journal-title":"Rheumatol. kead490"},{"key":"10.1016\/j.phrs.2025.107843_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12969-021-00629-8","article-title":"Juvenile idiopathic arthritis: from aetiopathogenesis to therapeutic approaches","volume":"19","author":"Zaripova","year":"2021","journal-title":"Pediatr. Rheumatol."},{"key":"10.1016\/j.phrs.2025.107843_bib6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/archdischild-2023-325668","article-title":"Inflammatory bowel disease: recent developments","volume":"109","author":"Ashton","year":"2024","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.phrs.2025.107843_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/ajg.2017.228","article-title":"Dramatic Increase in Incidence of Ulcerative Colitis and Crohn\u2019s Disease (1988\u20132011): A Population-Based Study of French Adolescents","volume":"113","author":"Ghione","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.phrs.2025.107843_bib8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamapediatrics.2015.1982","article-title":"Inflammatory Bowel Disease in Children and Adolescents","volume":"169","author":"Rosen","year":"2015","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.phrs.2025.107843_bib9","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1365-2133.2009.09593.x","article-title":"Epidemiology and comorbidity of psoriasis in children: Epidemiology and comorbidity of psoriasis in children","volume":"162","author":"Augustin","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.phrs.2025.107843_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/12034754241293138","article-title":"Hidradenitis Suppurativa from a Multi-Omic Scope","volume":"29","author":"Garbayo-Salmons","year":"2025","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.phrs.2025.107843_bib11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40348-024-00177-7","article-title":"Immune-mediated inflammatory diseases (IMIDs) in children: key research questions and some answers","volume":"11","author":"Kallinich","year":"2024","journal-title":"Mol. Cell. Pediatr."},{"key":"10.1016\/j.phrs.2025.107843_bib12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11894-020-00773-3","article-title":"The Treatment of Pediatric Inflammatory Bowel Disease with Biologic Therapies","volume":"22","author":"Conrad","year":"2020","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.phrs.2025.107843_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12969-021-00514-4","article-title":"Biologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology \u2013 what we know and what we do not know from randomized controlled trials","volume":"19","author":"Welzel","year":"2021","journal-title":"Pediatr. Rheumatol."},{"key":"10.1016\/j.phrs.2025.107843_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107074","article-title":"Comparing clinical trial population representativeness to real-world users of 17 biologics approved for immune-mediated inflammatory diseases: An external validity analysis of 66,639 biologic users from the Italian VALORE project","volume":"200","author":"Ingrasciotta","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2025.107843_bib15","doi-asserted-by":"crossref","first-page":"SI170","DOI":"10.1093\/rheumatology\/keac299","article-title":"Pharmacological treatment patterns in patients with juvenile idiopathic arthritis in the Netherlands: a real-world data analysis","volume":"62","author":"Kip","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.phrs.2025.107843_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12969-022-00682-x","article-title":"Real-world data reveals the complexity of disease modifying anti-rheumatic drug treatment patterns in juvenile idiopathic arthritis: an observational study","volume":"20","author":"Grazziotin","year":"2022","journal-title":"Pediatr. Rheumatol."},{"key":"10.1016\/j.phrs.2025.107843_bib17","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1001\/jamadermatol.2022.2909","article-title":"Drug Survival Associated With Effectiveness and Safety of Treatment With Guselkumab, Ixekizumab, Secukinumab, Ustekinumab, and Adalimumab in Patients With Psoriasis","volume":"158","author":"Yiu","year":"2022","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.phrs.2025.107843_bib18","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/ibd\/izz001","article-title":"Real-world Pattern of Biologic Use in Patients With Inflammatory Bowel Disease: Treatment Persistence, Switching, and Importance of Concurrent Immunosuppressive Therapy","volume":"25","author":"Chen","year":"2019","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.phrs.2025.107843_bib19","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/MPG.0000000000002857","article-title":"Discontinuation of Immunosuppressive Medications in Children With Inflammatory Bowel Disease on Combination Therapy","volume":"71","author":"El-Matary","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.phrs.2025.107843_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jamadermatol.2022.6325","article-title":"Risk of Infection in Children With Psoriasis Receiving Treatment With Ustekinumab, Etanercept, or Methotrexate Before and After Labeling Expansion","volume":"159","author":"Schneeweiss","year":"2023","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.phrs.2025.107843_bib21","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00296-020-04774-3","article-title":"Comparative risk of infections among real-world users of biologics for juvenile idiopathic arthritis: data from the German BIKER registry","volume":"41","author":"Thiele","year":"2021","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.phrs.2025.107843_bib22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jpeds.2021.06.076","article-title":"Serious Infections in Pediatric Inflammatory Bowel Disease 2002-2017\u2014A Nationwide Cohort Study","volume":"238","author":"Ludvigsson","year":"2021","journal-title":"J. Pediatr."},{"key":"10.1016\/j.phrs.2025.107843_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/14740338.2016.1240783","article-title":"Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis","volume":"15","author":"Minozzi","year":"2016","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.phrs.2025.107843_bib24","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/rheumatology\/kex049","article-title":"Risk of serious bacterial infection associated with tumour necrosis factor-alpha inhibitors in children with juvenile idiopathic arthritis","volume":"57","author":"Lee","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.phrs.2025.107843_bib25","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.cgh.2014.01.021","article-title":"Risks of Serious Infection or Lymphoma With Anti\u2013Tumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease: A Systematic Review","volume":"12","author":"Dulai","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2025.107843_bib26","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s40259-021-00498-3","article-title":"Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project","volume":"35","author":"Trifir\u00f2","year":"2021","journal-title":"BioDrugs"},{"key":"10.1016\/j.phrs.2025.107843_bib27","unstructured":"European Medicines Agency. Post-marketing evaluation of the benefit-risk profile of originator biological drugs and biosimilars in the dermatological, rheumatological, gastroenterological and onco-hematological areas through the establishment of a single multiregional network for the integrated analysis of data from health databases, active surveillance and clinical registers - VALORE project, https:\/\/catalogues.ema.europa.eu\/node\/2833\/administrative-details (Accessed June 02, 2025)."},{"key":"10.1016\/j.phrs.2025.107843_bib28","unstructured":"demo - Resident population by age, sex and marital status. Istat - Istituto Nazionale di Statistica, https:\/\/demo.istat.it\/app\/?l=en&a=2024&i=POS (Accessed January 07, 2025)."},{"key":"10.1016\/j.phrs.2025.107843_bib29","unstructured":"Italian Medicines Agency. National report on medicines use in Italy - Year 2023, https:\/\/www.aifa.gov.it\/en\/-\/l-uso-dei-farmaci-in-italia-rapporto-osmed-2023 (Accessed June 02, 2025)."},{"key":"10.1016\/j.phrs.2025.107843_bib30","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2147\/CLEP.S445120","article-title":"Development and Validation of a META-Algorithm to Identify the Indications of Use of Biological Drugs Approved for the Treatment of Immune-Mediated Inflammatory Diseases from Claims Databases: Insights from the VALORE Project","volume":"16","author":"Spini","year":"2024","journal-title":"Clin. Epidemiol."},{"key":"10.1016\/j.phrs.2025.107843_bib31","unstructured":"World Health Organization. Defined Daily Dose (DDD), Definition and general considerations, https:\/\/www.who.int\/tools\/atc-ddd-toolkit\/about-ddd (Accessed January 07, 2025)."},{"issue":"7","key":"10.1016\/j.phrs.2025.107843_bib32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/BF03344156","article-title":"Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr)","volume":"29","author":"Cacciari","year":"2006","journal-title":"J. Endocrinol. Invest"},{"key":"10.1016\/j.phrs.2025.107843_bib33","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1093\/oxfordjournals.aje.a113244","article-title":"POWER CONSIDERATIONS IN EPIDEMIOLOGIC STUDIES OF VINYL CHLORIDE WORKERS","volume":"114","author":"Beaumont","year":"1981","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.phrs.2025.107843_bib34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/12034754231222415","article-title":"A Practical Guide to Using Biologics in Pediatric Dermatology","volume":"28","author":"George","year":"2024","journal-title":"J. Cutan. Med. Surg."},{"key":"10.1016\/j.phrs.2025.107843_bib35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s40257-021-00603-w","article-title":"Biologic Treatment Algorithms for Moderate-to-Severe Psoriasis with Comorbid Conditions and Special Populations: A Review","volume":"22","author":"Thatiparthi","year":"2021","journal-title":"Am. J. Clin. Dermatol."},{"issue":"8","key":"10.1016\/j.phrs.2025.107843_bib36","first-page":"400","article-title":"Positioning Biologic Therapies in the Management of Pediatric Inflammatory Bowel Disease","volume":"16","author":"Breton","year":"2020","journal-title":"Gastroenterol. Hepatol. (N. Y)"},{"key":"10.1016\/j.phrs.2025.107843_bib37","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/RHU.0000000000002035","article-title":"Impact of the COVID-19 Pandemic on the Management of Juvenile Idiopathic Arthritis: Analysis of United States Commercial Insurance Data","volume":"29","author":"Horton","year":"2023","journal-title":"JCR J. Clin. Rheumatol."},{"key":"10.1016\/j.phrs.2025.107843_bib38","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.3390\/jcm10112388","article-title":"Direct and Indirect Impact of COVID-19 for Patients with Immune-Mediated Inflammatory Diseases: A Retrospective Cohort Study","volume":"10","author":"Belleudi","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.phrs.2025.107843_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-045343","article-title":"Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review","volume":"11","author":"Moynihan","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.phrs.2025.107843_bib40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","article-title":"Prevalence and incidence of juvenile idiopathic arthritis: A systematic review","volume":"81","author":"Thierry","year":"2014","journal-title":"Jt. Bone Spine"},{"key":"10.1016\/j.phrs.2025.107843_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/461078","article-title":"The Role of Gender in Juvenile Idiopathic Arthritis-Associated Uveitis","volume":"2014","author":"Moradi","year":"2014","journal-title":"J. Ophthalmol."},{"key":"10.1016\/j.phrs.2025.107843_bib42","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/1346-8138.17049","article-title":"Pediatric psoriasis: Understanding pathological conditions and advances in treatment","volume":"51","author":"Morita","year":"2024","journal-title":"J. Dermatol."},{"key":"10.1016\/j.phrs.2025.107843_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1684\/ejd.2016.2932","article-title":"Childhood psoriasis","volume":"26","author":"Mah\u00e9","year":"2016","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.phrs.2025.107843_bib44","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/acr.23870","article-title":"2019 American College of Rheumatology\/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non-Systemic Polyarthritis, Sacroiliitis, and Enthesitis","volume":"71","author":"Ringold","year":"2019","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.phrs.2025.107843_bib45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaad.2019.05.056","article-title":"Management of pediatric plaque psoriasis using biologics","volume":"82","author":"Lansang","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.phrs.2025.107843_bib46","unstructured":"European Medicines Agency. Humira - Procedural steps taken and scientific information after the authorization, https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/humira (Accessed February 10, 2025)."},{"key":"10.1016\/j.phrs.2025.107843_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40272-021-00436-4","article-title":"Prescribing Patterns and Impact of Factors Associated with Time to Initial Biologic Therapy among Children with Non-systemic Juvenile Idiopathic Arthritis","volume":"23","author":"Yue","year":"2021","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.phrs.2025.107843_bib48","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/1346-8138.16702","article-title":"Biologics in pediatric psoriasis","volume":"50","author":"Wang","year":"2023","journal-title":"J. Dermatol."},{"key":"10.1016\/j.phrs.2025.107843_bib49","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00431-017-2985-x","article-title":"Treatment of severe psoriasis in children: recommendations of an Italian expert group","volume":"176","author":"Fortina","year":"2017","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.phrs.2025.107843_bib50","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s13555-022-00758-2","article-title":"Update on the Management of Pediatric Psoriasis: An Italian Consensus","volume":"12","author":"Peris","year":"2022","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.phrs.2025.107843_bib51","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13075-016-1170-3","article-title":"Comparison of treatment response, remission rate and drug adherence in polyarticular juvenile idiopathic arthritis patients treated with etanercept, adalimumab or tocilizumab","volume":"18","author":"Horneff","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2025.107843_bib52","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1093\/rheumatology\/keac587","article-title":"Biologics with or without methotrexate in treatment of polyarticular juvenile idiopathic arthritis: effectiveness, safety and drug survival","volume":"62","author":"Thiele","year":"2023","journal-title":"Rheumatology"},{"key":"10.1016\/j.phrs.2025.107843_bib53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.dld.2023.04.017","article-title":"Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study","volume":"56","author":"Fumery","year":"2024","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.phrs.2025.107843_bib54","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.cgh.2024.03.043","article-title":"Characterization of Biologic Discontinuation Among Pediatric Patients With Crohn\u2019s Disease","volume":"22","author":"Ali","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2025.107843_bib55","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2147\/PPA.S303279","article-title":"Patient Preferences for Subcutaneous versus Intravenous Administration of Treatment for Chronic Immune System Disorders: A Systematic Review","volume":"15","author":"Overton","year":"2021","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.phrs.2025.107843_bib56","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.3390\/ijerph19116799","article-title":"Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks","volume":"19","author":"Giometto","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.phrs.2025.107843_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/11595980-000000000-00000","article-title":"Defining Juvenile Idiopathic Arthritis Remission and Optimum Time for Disease-Modifying Anti-Rheumatic Drug Withdrawal: Why We Need a Consensus","volume":"14","author":"Broughton","year":"2012","journal-title":"Pediatr. Drugs"},{"key":"10.1016\/j.phrs.2025.107843_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1479619","article-title":"Risk factors affecting relapse after discontinuation of biologics in children with Crohn\u2019s disease who maintained deep remission","volume":"12","author":"Kim","year":"2024","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.phrs.2025.107843_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12969-023-00897-6","article-title":"Biologic switching patterns among children with non-systemic juvenile idiopathic arthritis","volume":"21","author":"Pedersen","year":"2023","journal-title":"Pediatr. Rheumatol."},{"key":"10.1016\/j.phrs.2025.107843_bib60","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/rheumatology\/kev429","article-title":"Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers","volume":"55","author":"Kearsley-Fleet","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.phrs.2025.107843_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/pde.14845","article-title":"Switching biologics in children with psoriasis: Results from the BiPe cohort","volume":"39","author":"Phan","year":"2022","journal-title":"Pediatr. Dermatol."},{"key":"10.1016\/j.phrs.2025.107843_bib62","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1053\/j.gastro.2017.02.009","article-title":"Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions","volume":"152","author":"Loomba","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phrs.2025.107843_bib63","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.cgh.2022.07.032","article-title":"Comparative Risk of Serious Infections With Biologic Agents and Oral Small Molecules in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis","volume":"21","author":"Solitano","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2025.107843_bib64","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrrheum.2010.142","article-title":"The safety profile of biologic therapies for juvenile idiopathic arthritis","volume":"6","author":"Hashkes","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.phrs.2025.107843_bib65","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpeds.2018.08.065","article-title":"Risk of Serious Infections Associated with Biologic Agents in Juvenile Idiopathic Arthritis: A Systematic Review and Meta-Analyses","volume":"204","author":"Aeschlimann","year":"2019","journal-title":"J. Pediatr."},{"key":"10.1016\/j.phrs.2025.107843_bib66","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12969-019-0305-x","article-title":"The effects of TNF-alpha inhibitor therapy on the incidence of infection in JIA children: a meta-analysis","volume":"17","author":"Nagy","year":"2019","journal-title":"Pediatr. Rheumatol."},{"key":"10.1016\/j.phrs.2025.107843_bib67","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12876-023-03008-7","article-title":"Clinical importance of weight gain and associated factors in patients with moderate to severe ulcerative colitis: results from the MOSAIK cohort in Korea","volume":"23","author":"Yoon","year":"2023","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.phrs.2025.107843_bib68","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s40259-020-00444-9","article-title":"Changes in Anthropometric Parameters After Anti-TNF\u03b1 Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","volume":"34","author":"Mazhar","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.phrs.2025.107843_bib69","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41430-022-01245-9","article-title":"Body composition, physical activity, and quality of life in pediatric patients with inflammatory bowel disease on anti-TNF therapy\u2014an observational follow-up study","volume":"77","author":"Boros","year":"2023","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.phrs.2025.107843_bib70","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13052-018-0584-8","article-title":"Off-label drugs use in pediatric palliative care","volume":"44","author":"De Zen","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"10.1016\/j.phrs.2025.107843_bib71","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40265-024-01993-x","article-title":"Adult-Onset Still\u2019s Disease (AOSD): Advances in Understanding Pathophysiology, Genetics and Emerging Treatment Options","volume":"84","author":"Bindoli","year":"2024","journal-title":"Drugs"},{"key":"10.1016\/j.phrs.2025.107843_bib72","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.vaccine.2024.01.037","article-title":"Background incidence rates of health outcomes in populations at risk for Lyme disease using US administrative claims data","volume":"42","author":"Dreyfus","year":"2024","journal-title":"Vaccine"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661825002683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:45:12Z","timestamp":1762353912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661825002683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":72,"alternative-id":["S1043661825002683"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107843","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trend in the use of biological drugs in pediatric patients with immune-mediated inflammatory diseases: Insight from the large-scale Italian VALORE project","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2025.107843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107843"}}